Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Current Assets (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Current Assets for 5 consecutive years, with $49.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets rose 196.26% year-over-year to $49.8 million, compared with a TTM value of $49.8 million through Sep 2025, up 196.26%, and an annual FY2024 reading of $25.1 million, up 13.93% over the prior year.
  • Current Assets was $49.8 million for Q3 2025 at Lucid Diagnostics, up from $33.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $57.3 million in Q4 2021 and bottomed at $2.5 million in Q3 2021.
  • Average Current Assets over 5 years is $31.6 million, with a median of $27.9 million recorded in 2024.
  • Peak annual rise in Current Assets hit 1091.73% in 2022, while the deepest fall reached 57.5% in 2022.
  • Year by year, Current Assets stood at $57.3 million in 2021, then plummeted by 57.5% to $24.4 million in 2022, then dropped by 9.37% to $22.1 million in 2023, then grew by 13.93% to $25.1 million in 2024, then skyrocketed by 98.19% to $49.8 million in 2025.
  • Business Quant data shows Current Assets for LUCD at $49.8 million in Q3 2025, $33.8 million in Q2 2025, and $27.5 million in Q1 2025.